Epidermal tight junctions in health and disease

Tissue Barriers

Volumn 3, Issue 1, 2015, Pages

  Brandner, J M ^a   Zorn Kruppa, M ^a   Yoshida, T ^b   Moll, I ^a   Beck, L A ^b   De Benedetto, A ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Claudins; Skin barrier; Skin immune system; Skin innate barrier; Tight junction

Indexed keywords

ADENOSINE TRIPHOSPHATE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CLAUDIN 1; CLAUDIN 7; EPIDERMAL GROWTH FACTOR; FILAGGRIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LORICRIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OCCLUDIN; PATTERN RECOGNITION RECEPTOR; PROTEIN ZO1; PSORIASIN; T6 ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; UVOMORULIN;

ALLERGIC RHINITIS; ATOPIC DERMATITIS; CELL DIFFERENTIATION; DENDRITIC CELL; EPIDERMIS CELL; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; MELANOMA; PROTEIN EXPRESSION; PSORIASIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; SKIN WATER LOSS; SQUAMOUS CELL CARCINOMA; STRATUM CORNEUM; TIGHT JUNCTION; TRANSEPITHELIAL RESISTANCE;

EID: 84980036943     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.4161/21688370.2014.974451     Document Type: Review

References (127)

1. Chu D.H. HAR, Holbrook K., Loomis C. A. Fitzpatrick’s Dermatology in General Medicine. McGraw-Hill Companies, Inc. 6(1):58-88.
2. Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harbor Perspect Biol 2009; 1:a002584; PMID:20066090; http://dx.doi.org/10.1101/cshperspect.a002584.
3. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009; 206:2937-46; PMID:19995951; http://dx.doi.org/10.1084/jem.20091527.
4. Takano K, Kojima T, Go M, Murata M, Ichimiya S, Himi T, Sawada N. HLA-DR-and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis. Journal Histochem Cytochem: Off J Histochem Soc 2005; 53:611-9; PMID:15872054; http://dx.doi.org/10.1369/jhc.4A6539.2005.
5. Madison KC. Barrier function of the skin: “la raison d’etre” of the epidermis. J Invest Dermatol 2003; 121:231-42; PMID:12880413; http://dx.doi.org/10.1046/j.1523-1747.2003.12359.x.
6. S. Rothman PF. The Physiology of the skin. Ann Rev Physiol 1944; 6:195-224; http://dx.doi.org/10.1146/annurev.ph.06.030144.001211.
7. Hashimoto K. Intercellular spaces of the human epidermis as demonstrated with lanthanum. J Invest Dermatol 1971; 57:17-31; PMID:4104141; http://dx.doi.org/10.1111/1523-1747.ep12292052.
8. Pummi K, Malminen M, Aho H, Karvonen S-L, Peltonen J, Peltonen S. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol 2001; 117:1050-8; PMID:11710912; http://dx.doi.org/10.1046/j.0022-202x.2001.01493.x.
9. Schluter H, Wepf R, Moll I, Franke WW. Sealing the live part of the skin: the integrated meshwork of desmosomes, tight junctions and curvilinear ridge structures in the cells of the uppermost granular layer of the human epidermis. Eur J Cell Biol 2004; 83:655-65; PMID:15679110; http://dx.doi.org/10.1078/0171-9335-00434.
10. Brandner JM, Kief S, Grund C, Rendl M, Houdek P, Kuhn C, Tschachler E, Franke WW, Moll I. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol 2002; 81:253-63; PMID:12067061; http://dx.doi.org/10.1078/0171-9335-00244.
11. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S. Claudinbased tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002; 156:1099-111; PMID: 11889141; http://dx.doi.org/10.1083/jcb.200110122.
12. Turksen K, Troy TC. Permeability barrier dysfunction in transgenic mice overexpressing claudin. Development 2002; 129:1775-84; PMID:11923212.
13. Green KJ, Jones JC. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J: Off Pub Fed Am Soc Exp Biol 1996; 10:871-81; PMID:8666164.
14. Langbein L, Grund C, Kuhn C, Praetzel S, Kartenbeck J, Brandner JM, Moll I, Franke WW. Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur J Cell Biol 2002; 81:419-35; PMID:12234014; http://dx.doi.org/10.1078/0171-9335-00270.
15. Ishida-Yamamoto A, Kishibe M, Murakami M, Honma M, Takahashi H, Iizuka H. Lamellar granule secretion starts before the establishment of tight junction barrier for paracellular tracers in mammalian epidermis. PLoS One 2012; 7:e31641; PMID:22328942; http://dx.doi.org/10.1371/journal.pone.0031641.
16. Kirschner N, Houdek P, Fromm M, Moll I, Brandner JM. Tight junctions form a barrier in human epidermis. Eur J Cell Biol 2010; 89:839-42; PMID:20732726; http://dx.doi.org/10.1016/j.ejcb.2010.07.010.
17. Schluter H, Moll I, Wolburg H, Franke WW. The different structures containing tight junction proteins in epidermal and other stratified epithelial cells, including squamous cell metaplasia. Eur J Cell Biol 2007; 86:645-55; PMID:17291627; http://dx.doi.org/10.1016/j.ejcb.2007.01.001.
18. Kirschner N, Rosenthal R, Gunzel D, Moll I, Brandner JM. Tight junctions and differentiation–a chicken or the egg question? Exp Dermatol 2012; 21:171-5; PMID:22379962; http://dx.doi.org/10.1111/j.1600-0625.2011.01431.x.
19. Kirschner N, Brandner JM. Barriers and more: functions of tight junction proteins in the skin. Ann N Y Acad Sci 2012; 1257:158-66; PMID:22671602; http://dx.doi.org/10.1111/j.1749-6632.2012.06554.x.
20. Rachow S, Zorn-Kruppa M, Ohnemus U, Kirschner N, Vidal-y-Sy S, von den Driesch P, Bornchen C, Eberle J, Mildner M, Vettorazzi E, et al. Occludin is involved in adhesion, apoptosis, differentiation and Ca2C-homeostasis of human keratinocytes: implications for tumorigenesis. PLoS One 2013; 8:e55116; PMID:23390516; http://dx.doi.org/10.1371/journal.pone.0055116.
21. Yoshida K, Yokouchi M, Nagao K, Ishii K, Amagai M, Kubo A. Functional tight junction barrier localizes in the second layer of the stratum granulosum of human epidermis. J Dermatol Sci 2013; 71:89-99; PMID:23712060; http://dx.doi.org/10.1016/j.jdermsci.2013.04.021.
22. Baek JH, Lee SE, Choi KJ, Choi EH, Lee SH. Acute modulations in stratum corneum permeability barrier function affect claudin expression and epidermal tight junction function via changes of epidermal calcium gradient. Yonsei Med J 2013; 54:523-8; PMID: 23364991; http://dx.doi.org/10.3349/ymj.2013.54.2.523.
23. Celli A, Zhai Y, Jiang YJ, Crumrine D, Elias PM, Feingold KR, Mauro TM. Tight junction properties change during epidermis development. Exp Dermatol 2012; 21:798-801; PMID:22882565.
24. Kirschner N, Rosenthal R, Furuse M, Moll I, Fromm M, Brandner JM. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest Dermatol 2013; 133 1161-9; PMID:23407391; http://dx.doi.org/10.1038/jid.2012.507.
25. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 2011; 127:773-86 e1-7; PMID:21163515; http://dx.doi.org/10.1016/j.jaci.2010.10.018.
26. Helfrich I, Schmitz A, Zigrino P, Michels C, Haase I, le Bivic A, Leitges M, Niessen CM. Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation. J Invest Dermatol 2007; 127:782-91; PMID:17110935; http://dx.doi.org/10.1038/sj.jid.5700621.
27. Mertens AE, Rygiel TP, Olivo C, van der Kammen R, Collard JG. The Rac activator Tiam1 controls tight junction biogenesis in keratinocytes through binding to and activation of the Par polarity complex. J Cell Biol 2005; 170:1029-37; PMID:16186252; http://dx.doi.org/10.1083/jcb.200502129.
28. Yuki T, Haratake A, Koishikawa H, Morita K, Miyachi Y, Inoue S. Tight junction proteins in keratinocytes: localization and contribution to barrier function. Exp Dermatol 2007; 16:324-30; PMID: 17359339; http://dx.doi.org/10.1111/j.1600-0625.2006. 00539.x.
29. Yuki T, Hachiya A, Kusaka A, Sriwiriyanont P, Visscher MO, Morita K, Muto M, Miyachi Y, Sugiyama Y, Inoue S. Characterization of tight junctions and their disruption by UVB in human epidermis and cultured keratinocytes. J Invest Dermatol 2011; 131:744-52; PMID:21160495; http://dx.doi.org/10.1038/jid.2010.385.
30. Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, Amasheh S, Gunzel D, Fromm M. Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 2010; 123:1913-21; PMID: 20460438; http://dx.doi.org/10.1242/jcs.060665.
31. Kirschner N, Haftek M, Niessen CM, Behne MJ, Furuse M, Moll I, Brandner JM. CD44 regulates tightjunction assembly and barrier function. J Invest Dermatol 2011; 131:932-43; PMID:21191420; http://dx.doi.org/10.1038/jid.2010.390.
32. Sugawara T, Iwamoto N, Akashi M, Kojima T, Hisatsune J, Sugai M, Furuse M. Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice. J Dermatol Sci 2013; 70:12-8; PMID:23433550; http://dx.doi.org/10.1016/j.jdermsci.2013.01.002.
33. Matter K, Aijaz S, Tsapara A, Balda MS. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 2005; 17:453-8; PMID:16098725; http://dx.doi.org/10.1016/j.ceb.2005.08.003.
34. Gunzel D, Zakrzewski SS, Schmid T, Pangalos M, Wiedenhoeft J, Blasse C, Ozboda C, Krug SM. From TER to trans-and paracellular resistance: lessons from impedance spectroscopy. Ann N Y Acad Sci 2012; 1257:142-51; PMID:22671600; http://dx.doi.org/10.1111/j.1749-6632.2012.06540.x.
35. Krug SM, Amasheh S, Richter JF, Milatz S, Gunzel D, Westphal JK, Huber O, Schulzke JD, Fromm M. Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. Mol Biol Cell 2009; 20:3713-24; PMID:19535456; http://dx.doi.org/10.1091/mbc.E09-01-0080.
36. Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 2011; 73:283-309; PMID: 20936941; http://dx.doi.org/10.1146/annurev-physiol-012110-142150.
37. Tunggal JA, Helfrich I, Schmitz A, Schwarz H, Gunzel D, Fromm M, Kemler R, Krieg T, Niessen CM. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. Embo J 2005; 24:1146-56; PMID:15775979; http://dx.doi.org/10.1038/sj.emboj.7600605.
38. Heath WR, Carbone FR. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 2013; 14:978-85; PMID:24048119; http://dx.doi.org/10.1038/ni.2680.
39. Nakatsuji T, Gallo RL. Antimicrobial peptides: old molecules with new ideas. J Invest Dermatol 2012; 132:887-95; PMID:22158560; http://dx.doi.org/10.1038/jid.2011.387.
40. Kuo IH, Yoshida T, De Benedetto A, Beck LA. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol 2013; 131:266-78; PMID:23374259; http://dx.doi.org/10.1016/j.jaci.2012.12.1563.
41. Esche C, de Benedetto A, Beck LA. Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep 2004; 4:276-84; PMID:15175141; http://dx.doi.org/10.1007/s11882-004-0071-8.
42. Esche C, Stellato C, Beck LA. Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 2005; 125:615-28; PMID:16185259; http://dx.doi.org/10.1111/j.0022-202X.2005.23841.x.
43. Tay SS, Roediger B, Tong PL, Tikoo S, Weninger W. The skin-resident immune network. Curr Dermatol Rep 2014; 3:13-22; PMID:24587975; http://dx.doi.org/10.1007/s13671-013-0063-9.
44. Furrie E, Macfarlane S, Thomson G, Macfarlane GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005; 115:565-74; PMID:16011525; http://dx.doi.org/10.1111/j.1365-2567.2005.02200.x.
45. Rhee SH, Im E, Riegler M, Kokkotou E, O’Brien M, Pothoulakis C. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Nat Acad Sci U S A 2005; 102:13610-5; PMID:16157881; http://dx.doi.org/10.1073/pnas.0502174102.
46. Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochimica et Biophysica Acta 2009; 1788:832-41; PMID:19059200; http://dx.doi.org/10.1016/j.bbamem.2008.10.028.
47. Baranowski E, Ruiz-Jarabo CM, Domingo E. Evolution of cell recognition by viruses. Science 2001; 292:1102-5; PMID:11352064; http://dx.doi.org/10.1126/science.1058613.
48. Holmes EC, Drummond AJ. The evolutionary genetics of viral emergence. Curr Topics Microbiol Immunol 2007; 315:51-66; PMID:17848060.
49. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 1998; 280:1618-20; PMID:9616127; http://dx.doi.org/10.1126/science.280.5369.1618.
50. Schelhaas M, Jansen M, Haase I, Knebel-Morsdorf D. Herpes simplex virus type 1 exhibits a tropism for basal entry in polarized epithelial cells. J Gen Virol 2003; 84:2473-84; PMID:12917468; http://dx.doi.org/10.1099/vir.0.19226-0.
51. De Benedetto A, Slifka MK, Rafaels NM, Kuo IH, Georas SN, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, et al. Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol 2011; 128:242-6 e5; PMID:21489616; http://dx.doi.org/10.1016/j.jaci.2011.02.014.
52. Kramer SC, Thomas CJ, Tyler WB, Elston DM. Kaposi’s varicelliform eruption: a case report and review of the literature. Cutis 2004; 73:115-22; PMID:15027517.
53. Santmyire-Rosenberger BR, Nigra TP. Psoriasis herpeticum: three cases of Kaposi’s varicelliform eruption in psoriasis. J Am Acad Dermatol 2005; 53:52-6; PMID:15965420; http://dx.doi.org/10.1016/j.jaad.2005.01.140.
54. Yuki T, Yoshida H, Akazawa Y, Komiya A, Sugiyama Y, Inoue S. Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes. J Immunol 2011; 187:3230-7; PMID:21841130; http://dx.doi.org/10.4049/jimmunol.1100058.
55. Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC, Gallo RL, Borkowski AW, Yamasaki K, Leung DY, et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 2013; 133:988-98; PMID: 23223142; http://dx.doi.org/10.1038/jid.2012.437.
56. Akiyama T, Niyonsaba F, Kiatsurayanon C, Nguyen TT, Ushio H, Fujimura T, Ueno T, Okumura K, Ogawa H, Ikeda S. The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function. J Innate Immun 2014; 6:739-53; PMID:24862212; http://dx.doi.org/10.1159/000362789.
57. Hattori F, Kiatsurayanon C, Okumura K, Ogawa H, Ikeda S, Okamoto K, Niyonsaba F. The antimicrobial protein S100A7psoriasin enhances expression of keratinocyte differentiation markers and strengthens the skin tight junction barrier. Br J Dermatol 2014; 171:742-53; PMID:24842328; http://dx.doi.org/10.1111/bjd.13125.
58. Kiatsurayanon C, Niyonsaba F, Smithrithee R, Akiyama T, Ushio H, Hara M, Okumura K, Ikeda S, Ogawa H. Host defense (Antimicrobial) peptide, human beta-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes. J Invest Dermatol 2014; 134:2163-73; PMID:24633129; http://dx.doi.org/10.1038/jid.2014.143.
59. Ohnemus U, Kohrmeyer K, Houdek P, Rohde H, Wladykowski E, Vidal S, Horstkotte MA, Aepfelbacher M, Kirschner N, Behne MJ, et al. Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J Invest Dermatol 2008; 128:906-16; PMID: 17914452; http://dx.doi.org/10.1038/sj.jid.5701070.
60. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol 2011; 9:244-53; PMID:21407241; http://dx.doi.org/10.1038/nrmicro2537.
61. Proksch E, Brasch J, Sterry W. Integrity of the permeability barrier regulates epidermal Langerhans cell density. Br J Dermatol 1996; 134:630-8; PMID: 8733362; http://dx.doi.org/10.1111/j.1365-2133.1996. tb06961.x.
62. Proksch E, Brasch J. Influence of epidermal permeability barrier disruption and Langerhans’ cell density on allergic contact dermatitis. Acta Dermato-Venereologica 1997; 77:102-4; PMID:9111817.
63. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2:361-7; PMID:11276208; http://dx.doi.org/10.1038/86373.
64. Zimmerli SC, Hauser C. Langerhans cells and lymph node dendritic cells express the tight junction component claudin-1. J Invest Dermatol 2007; 127:2381-90; PMID:17508021; http://dx.doi.org/10.1038/sj. jid.5700882.
65. Kirschner N, Poetzl C, von den Driesch P, Wladykowski E, Moll I, Behne MJ, Brandner JM. Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines. Am J Pathol 2009; 175:1095-106; PMID:19661441; http://dx.doi.org/10.2353/ajpath.2009.080973.
66. Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 1983; 80 Suppl:12s-6s; PMID:6602189; http://dx.doi.org/10.1111/1523-1747.ep12536743.
67. Ellinghaus D, Baurecht H, Esparza-Gordillo J, Rodriguez E, Matanovic A, Marenholz I, Hubner N, Schaarschmidt H, Novak N, Michel S, et al. Highdensity genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet 2013; 45:808-12; PMID:23727859; http://dx.doi.org/10.1038/ng.2642.
68. Angelova-Fischer I, Fernandez IM, Donnadieu MH, Bulfone-Paus S, Zillikens D, Fischer TW, Soumelis V. Injury to the stratum corneum induces in vivo expression of human thymic stromal lymphopoietin in the epidermis. J Invest Dermatol 2010; 130:2505-7; PMID:20555350; http://dx.doi.org/10.1038/jid.2010.143.
69. Dickel H, Gambichler T, Kamphowe J, Altmeyer P, Skrygan M. Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL-33, TNF-alpha and IL-8CXCL8 mRNA: new insights into the involvement of ‘alarmins’. Contact Dermatitis 2010; 63:215-22; PMID:20731692; http://dx.doi.org/10.1111/j.1600-0536.2010.01769.x.
70. Chuong CM, Nickoloff BJ, Elias PM, Goldsmith LA, Macher E, Maderson PA, Sundberg JP, Tagami H, Plonka PM, Thestrup-Pederson K, et al. What is the ‘true’ function of skin? Exp Dermatol 2002; 11:159-87; PMID:11994143; http://dx.doi.org/10.1034/j.1600-0625.2002.00112.x.
71. Bohner C, A. PM, Haass NK, Zorn-Kruppa M, von den Driesch P, Schaider H, Brandner JM. The role(s) of the tight junction protein ZO-1 in malignant melanoma. Exp Dermatol 2012; 21:e47.
72. Gutowska-Owsiak D, Schaupp AL, Salimi M, Selvakumar TA, McPherson T, Taylor S, Ogg GS. IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Exp Dermatol 2012; 21:104-10; PMID:22229441; http://dx.doi.org/10.1111/j.1600-0625.2011.01412.x.
73. Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, Redzic JS, Hansen KC, Leung DY. Th2 cytokines act on S100A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128:2248-58; PMID:18385759; http://dx.doi.org/10.1038/jid.2008.74.
74. Gschwandtner M, Mildner M, Mlitz V, Gruber F, Eckhart L, Werfel T, Gutzmer R, Elias PM, Tschachler E. Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy 2013; 68:37-47; PMID: 23157658; http://dx.doi.org/10.1111/all.12051.
75. Hvid M, Vestergaard C, Kemp K, Christensen GB, Deleuran B, Deleuran M. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 2011; 131:150-7; PMID:20861853; http://dx.doi.org/10.1038/jid.2010.277.
76. Ivanov AI, Nusrat A, Parkos CA. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novart Found Symp 2004; 263:115-24; discussion 24-32, 211-8; PMID:15669638; http://dx.doi.org/10.1002/0470090480.ch9.
77. Kim BE, Howell MD, Guttman-Yassky E, Gilleaudeau PM, Cardinale IR, Boguniewicz M, Krueger JG, Leung DY. TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier. J Invest Dermatol 2011; 131:1272-9; PMID:21346775; http://dx.doi.org/10.1038/jid.2011.24.
78. Di Cesare A, Di Meglio P, Nestle FO. The IL-23Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009; 129:1339-50; PMID:19322214; http://dx.doi.org/10.1038/jid.2009.59.
79. Koga C, Kabashima K, ShiraishiN, KobayashiM, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128:2625-30; PMID: 18432274; http://dx.doi.org/10.1038/jid.2008.111.
80. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000; 118:1001-11; PMID:10833473; http://dx.doi.org/10.1016/S0016-5085(00)70351-9.
81. De Benedetto A, Yoshida T, Kuo IH, Georas SN, Ivanov A, Beck LA. Effect of Th2 and Th17 cytokines on human epidermal tight junctions. J Allergy Clin Immunol 2010; 129:ab205.
82. Perera GK, Di Meglio P, Nestle FO. Psoriasis. Ann Rev Pathol 2012; 7:385-422; PMID:22054142; http://dx.doi.org/10.1146/annurev-pathol-011811-132448.
83. Brandner JM, Kief S, Wladykowski E, Houdek P, Moll I. Tight junction proteins in the skin. Skin Pharmacol Physiol 2006; 19:71-7; PMID:16685145; http://dx.doi.org/10.1159/000091973.
84. Peltonen S, Riehokainen J, Pummi K, Peltonen J. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Br J Dermatol 2007; 156:466-72; PMID:17300235; http://dx.doi.org/10.1111/j.1365-2133.2006.07642.x.
85. Yoshida Y, Morita K, Mizoguchi A, Ide C, Miyachi Y. Altered expression of occludin and tight junction formation in psoriasis. Arch Dermatol Res 2001; 293:239-44; PMID:11409568; http://dx.doi.org/10.1007/s004030100221.
86. Watson RE, Poddar R, Walker JM, McGuill I, Hoare LM, Griffiths CE, O’Neill CA. Altered claudin expression is a feature of chronic plaque psoriasis. J Pathol 2007; 212:450-8; PMID:17582238; http://dx.doi.org/10.1002/path.2200.
87. Beck L, Fridy S, Yoshida T, Kuo I-H, De Benedetto A. Does filaggrin deficiency alter epidermal tight junctions and tissue inflammation? J Invest Dermatol 2014; 134:S67.
88. Yoshida T, Swan J, Juskiewicz I, Almudevar A, De Benedetto A, Scott G, Ritchlin C, Duffy N, Tausk F, Moynihan J, Beck LA. Altered expression of epidermal barrier proteins and inflammatory markers in psoriatic skin biopsies. J Invest Dermatol 2014; 134:S68; http://dx.doi.org/10.1038/jid.2013.224.
89. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 30:35-9; PMID:8277028; http://dx.doi.org/10.1016/S0190-9622(94)70004-4.
90. Ong PY, Leung DY. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep 2006; 6:384-9; PMID:16899200; http://dx.doi.org/;http://dx.doi.org/10.1007/s11882-996-0008-5.
91. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009; 129:14-30; PMID:19078985; http://dx.doi.org/10.1038/jid.2008.259.
92. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009; 129:1892-908; PMID:19494826; http://dx.doi.org/10.1038/jid.2009.133.
93. De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol 2012; 132:949-63; PMID:22217737; http://dx.doi.org/10.1038/jid.2011.435.
94. Imokawa G. Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 2001; 45:S29-32; PMID: 11423869; http://dx.doi.org/10.1067/mjd.2001.117020.
95. Murata Y, Ogata J, Higaki Y, Kawashima M, Yada Y, Higuchi K, Tsuchiya T, Kawainami S, Imokawa G. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996; 106:1242-9; PMID:8752664; http://dx.doi.org/10.1111/1523-1747.ep12348937.
96. Pilgram GS, Vissers DC, van der Meulen H, Pavel S, Lavrijsen SP, Bouwstra JA, Koerten HK. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001; 117:710-7; PMID:11564181; http://dx.doi.org/10.1046/j.0022-202x.2001.01455.x.
97. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441-6; PMID:16550169; http://dx.doi.org/10.1038/ng1767.
98. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, Duff GW, Ward SJ, Tazi-Ahnini R. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118:3-21; quiz 2-3; PMID:16815133; http://dx.doi.org/10.1016/j.jaci.2006.04.042.
99. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2009; 124:R7-R12; PMID:19720210; http://dx.doi.org/10.1016/j.jaci.2009.07.012.
100. Ross-Hansen K, Linneberg A, Johansen JD, Hersoug LG, Brasch-Andersen C, Menne T, Thyssen JP. The role of glutathione S-transferase and claudin-1 gene polymorphisms in contact sensitization: a cross-sectional study. Br J Dermatol 2013; 168:762-70; PMID:23136956; http://dx.doi.org/10.1111/bjd.12126.
101. Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M, Lyonnet S, De Prost Y, Munnich A, Hadchouel M, et al. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology 2004; 127:1386-90; PMID:15521008; http://dx.doi.org/10.1053/j.gastro.2004.07.022.
102. Gruber R, Elias PM, Crumrine D, Lin TK, Brandner JM, Hachem JP, Presland RB, Fleckman P, Janecke AR, Sandilands A, et al. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 2011; 178:2252-63; PMID:21514438; http://dx.doi.org/10.1016/j. ajpath.2011.01.053.
103. Saunders SP, Goh CS, Brown SJ, Palmer CN, Porter RM, Cole C, Campbell LE, Gierlinski M, Barton GJ, Schneider G, et al. Tmem79Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. J Allergy Clin Immunol 2013; 132:1121-9; PMID:24084074; http://dx.doi.org/10.1016/j.jaci.2013.08.046.
104. Nakai K, Yoneda K, Hosokawa Y, Moriue T, Presland RB, Fallon PG, Kabashima K, Kosaka H, Kubota Y. Reduced expression of epidermal growth factor receptor, E-cadherin, and occludin in the skin of flaky tail mice is due to filaggrin and loricrin deficiencies. Am J Pathol 2012; 181:969-77; PMID:22796440; http://dx.doi.org/10.1016/j.ajpath.2012.06.005.
105. Smalley KS, Brafford P, Haass NK, Brandner JM, Brown E, Herlyn M. Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 2005; 166:1541-54; PMID:15855653; http://dx.doi.org/10.1016/S0002-9440(10)62370-X.
106. Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, Prieto VG. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms. J Cutaneous Pathol 2005; 32:533-6; PMID:16115050; http://dx.doi.org/10.1111/j.0303-6987.2005.00324.x.
107. Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ, et al. Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 2007; 26:3846-56; PMID:17160014; http://dx.doi.org/10.1038/sj.onc.1210155.
108. Morita K, Tsukita S, Miyachi Y. Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen’s disease. Br J Dermatol 2004; 151:328-34; PMID:15327539; http://dx.doi.org/10.1111/j.1365-2133.2004.06029.x.
109. Morita K, Morita NI, Nemoto K, Nakamura Y, Miyachi Y, Muto M. Expression of claudin in melanoma cells. J Dermatol 2008; 35:36-8; PMID:18181775; http://dx.doi.org/10.1111/j.1346-8138.2007.00409.x.
110. Haass NK, Houdek P, Wladykowski E, Moll I, Brandner JM. Expression patterns of tight junction proteins in Merkel cell carcinoma. In: Baumann K I, Halata Z, Moll I, eds. The Merkel Cell. Berlin, Heidelberg: Springer-Verlag, 2003:223-6.
111. Werling AM, Doerflinger Y, Brandner JM, Fuchs F, Becker JC, Schrama D, Kurzen H, Goerdt S, Peitsch WK. Homo-and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching. Histopathology 2011; 58:286-303; PMID:21323954; http://dx.doi.org/10.1111/j.1365-2559.2011.03748.x.
112. Leonard JH, Bell JR, Kearsley JH. Characterization of cell lines established from Merkel-cell (“small-cell”) carcinoma of the skin. Int J Cancer 1993; 55:803-10; PMID:8244578; http://dx.doi.org/10.1002/ijc.2910550519.
113. Hintsala HR, Siponen M, Haapasaari KM, Karihtala P, Soini Y. Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin. Int J Clin Exp Pathol 2013; 6:2855-63; PMID:24294371.
114. Bello IO, Vilen ST, Niinimaa A, Kantola S, Soini Y, Salo T. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol 2008; 39:1212-20; PMID:18547615; http://dx.doi.org/10.1016/j.humpath.2007.12.015.
115. Paschoud S, Bongiovanni M, Pache JC, Citi S. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod Pathol 2007; 20:947-54; PMID:17585317; http://dx.doi.org/10.1038/modpathol.3800835.
116. Tobioka H, Tokunaga Y, Isomura H, Kokai Y, Yamaguchi J, Sawada N. Expression of occludin, a tight-junctionassociated protein, in human lung carcinomas. Virchows Arch 2004; 445:472-6; PMID:15232740; http://dx.doi.org/10.1007/s00428-004-1054-9.
117. Telgenhoff D, Ramsay S, Hilz S, Slusarewicz P, Shroot B. Claudin 2 mRNA and protein are present in human keratinocytes and may be regulated by alltrans-retinoic acid. Skin Pharmacol Physiol 2008; 21:211-7; PMID:18509255; http://dx.doi.org/10.1159/000135637.
118. Tatari MN, De Craene B, Soen B, Taminau J, Vermassen P, Goossens S, Haigh K, Cazzola S, Lambert J, Huylebroeck D, et al. ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteins. Cell Mol Life Sci 2014; PMID:24573695.
119. Brandner JM, McIntyre M, Kief S, Wladykowski E, Moll I. Expression and localization of tight junctionassociated proteins in human hair follicles. Arch Dermatol Res 2003; 295:211-21; PMID:12898148; http://dx.doi.org/10.1007/s00403-003-0418-3.
120. Troy TC, Rahbar R, Arabzadeh A, Cheung RM, Turksen K. Delayed epidermal permeability barrier formation and hair follicle aberrations in Inv-Cldn6 mice. Mech Dev 2005; 122:805-19; PMID:15908185; http://dx.doi.org/10.1016/j.mod.2005.03.001.
121. Gareus R, Huth M, Breiden B, Nenci A, Rosch N, Haase I, Bloch W, Sandhoff K, Pasparakis M. Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat Cell Biol 2007; 9:461-9; PMID:17351639; http://dx.doi.org/10.1038/ncb1560.
122. Morita K, Itoh M, Saitou M, Ando-Akatsuka Y, Furuse M, Yoneda K, Imamura S, Fujimoto K, Tsukita S. Subcellular distribution of tight junction-associated proteins (occludin, ZO-1, ZO-2) in rodent skin. J Invest Dermatol 1998; 110:862-6; PMID:9620290; http://dx.doi.org/10.1046/j.1523-1747.1998.00209.x.
123. Tran QT, Kennedy LH, Leon Carrion S, Bodreddigari S, Goodwin SB, Sutter CH, Sutter TR. EGFR regulation of epidermal barrier function. Physiol Genomics 2012; 44:455-69; PMID:22395315; http://dx.doi.org/10.1152/physiolgenomics.00176.2011.
124. Hernandez-Monge J, Garay E, Raya-Sandino A, Vargas-Sierra O, Diaz-Chavez J, Popoca-Cuaya M, Lambert PF, Gonzalez-Mariscal L, Gariglio P. Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis. Exp Cell Res 2013; 319:2588-603; PMID:23948304; http://dx.doi.org/10.1016/j.yexcr.2013.07.028.
125. Yang J, Meyer M, Muller AK, Bohm F, Grose R, Dauwalder T, Verrey F, Kopf M, Partanen J, Bloch W, et al. Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis. J Cell Biol 2010; 188:935-52; PMID:20308431; http://dx.doi.org/10.1083/jcb.200910126.
126. Goto H, Hongo M, Ohshima H, Kurasawa M, Hirakawa S, Kitajima Y. Human beta defensin-1 regulates the development of tight junctions in cultured human epidermal keratinocytes. J Dermatol Sci 2013; 71:145-8; PMID:23712061; http://dx.doi.org/10.1016/j.jdermsci.2013.04.017.
127. Vockel M, Breitenbach U, Kreienkamp HJ, Brandner JM. Somatostatin regulates tight junction function and composition in human keratinocytes. Exp Dermatol 2010; 19:888-94; PMID:20629740; http://dx.doi.org/10.1111/j.1600-0625.2010.01101.x